Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Director/PDMR Shareholding

22 Mar 2017 10:30

RNS Number : 1937A
Huntsworth PLC
22 March 2017
 

 

22 March 2017

 

Huntsworth plc

(Huntsworth or the Company)

Director/PDMR Shareholding

Huntsworth plc, the healthcare communications and public relations group, announces that on 21 March 2017 (Date of Grant), an award under The Huntsworth Long Term Incentive Plan 2016 was made to Paul Taaffe, Chief Executive Officer, and Neil Jones, Chief Financial Officer, as set out below.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Taaffe

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

HUNTSWORTH PLC

b)

 

LEI

 

 

213800VWB9DDVXF1Q771

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each in the share capital of Huntsworth plc

 

 

 

 

Identification code

GB00B0CRWK29

 

 

b)

 

Nature of the transaction

 

 

Grant of a conditional nil-cost share award over Company shares with a market value equivalent to £600,000 at the Date of Grant, under The Huntsworth Long Term Incentive Plan 2016. The number of ordinary shares of 1p each in the capital of the Company granted was determined by the closing middle-market share price on the dealing day before the Date of Grant, being 40.75 pence per share. Vesting is subject to meeting performance conditions relating to earnings per share and relative total shareholder return. Subject to satisfying the relevant performance conditions, the award will normally vest on the third anniversary of the Date of Grant.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

Nil

1,472,392

 

 

 

 

 

 

d)

 

Aggregated information

Not applicable - single transaction

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

21 March 2017

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Neil Jones

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

HUNTSWORTH PLC

b)

 

LEI

 

 

213800VWB9DDVXF1Q771

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each in the share capital of Huntsworth plc

 

 

 

 

Identification code

GB00B0CRWK29

 

 

b)

 

Nature of the transaction

 

 

Grant of a nil-cost share award over Company shares with a market value equivalent to £350,000 at the Date of Grant, under The Huntsworth Long Term Incentive Plan 2016. The number of ordinary shares of 1p each in the capital of the Company granted was determined by the closing middle-market share price on the dealing day before the Date of Grant, being 40.75 pence per share. Vesting is subject to meeting performance conditions relating to earnings per share and relative total shareholder return. Subject to satisfying the relevant performance conditions, the award will normally vest on the third anniversary of the Date of Grant and can be exercised for a period of seven years from the vesting date.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

Nil

858,895

 

 

 

 

 

 

d)

 

Aggregated information

Not applicable - single transaction

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

21 March 2017

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

Enquiries to:

 

Citigate Dewe Rogerson

+44 (0)20 7638 9571

Simon Rigby

 

Georgia Colkin

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHJTMLTMBJTMRR
Date   Source Headline
19th Dec 20193:51 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSTrading Update
6th Dec 20191:59 pmRNSHoldings in Company
2nd Dec 201910:54 amRNSTotal Voting Rights
11th Nov 201910:31 amRNSHolding(s) in Company
6th Nov 20199:11 amRNSDirector Declaration
5th Nov 20195:31 pmRNSHolding(s) in Company
5th Nov 20197:00 amRNSAdditional Listing
1st Nov 20197:00 amRNSTotal Voting Rights and Capital
30th Oct 201910:22 amRNSDirector Declaration
15th Oct 20197:00 amRNSAdditional Listing
3rd Oct 201911:59 amRNSScrip Dividend Alternative
1st Oct 20197:00 amRNSBoard Changes
30th Sep 201911:35 amRNSNotification of Major Holdings
4th Sep 201912:07 pmRNSSecond Price Monitoring Extn
4th Sep 201912:02 pmRNSPrice Monitoring Extension
2nd Sep 20197:00 amRNSTotal Voting Rights and Capital
15th Aug 20197:00 amRNSAdditional Listing
8th Aug 201912:02 pmRNSPrice Monitoring Extension
1st Aug 201911:52 amRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSTotal Voting Rights
31st Jul 20194:41 pmRNSSecond Price Monitoring Extn
31st Jul 20194:35 pmRNSPrice Monitoring Extension
29th Jul 201912:08 pmRNSSecond Price Monitoring Extn
29th Jul 201912:02 pmRNSPrice Monitoring Extension
24th Jul 20194:41 pmRNSSecond Price Monitoring Extn
24th Jul 20194:35 pmRNSPrice Monitoring Extension
23rd Jul 20197:00 amRNSInterim Results
22nd Jul 201912:02 pmRNSPrice Monitoring Extension
10th Jul 201910:00 amRNSDirector Declaration & Directorate Change
8th Jul 201911:43 amRNSStandard form for notification of major holdings
3rd Jul 20197:00 amRNSAdditional Listing
1st Jul 20197:00 amRNSTotal Voting Rights and Capital
13th Jun 20194:12 pmRNSDirector/PDMR Shareholding
12th Jun 201910:00 amRNSAdditional Listing
3rd Jun 20198:59 amRNSTotal Voting Rights
31st May 201910:28 amRNSFinal Dividend for 2018
29th May 20194:40 pmRNSSecond Price Monitoring Extn
29th May 20194:35 pmRNSPrice Monitoring Extension
24th May 20193:53 pmRNSNotification of Major Shareholdings
23rd May 20199:56 amRNSDirector/PDMR Shareholding
23rd May 20199:51 amRNSDirector/PDMR Shareholding
21st May 20197:01 amRNSCC and Kyne acquisitions announcement
9th May 20192:23 pmRNSResults of Annual General Meeting
9th May 20197:00 amRNSTrading Update
12th Apr 20197:00 amRNSCapital Markets Day
11th Apr 20194:40 pmRNSSecond Price Monitoring Extn
11th Apr 20194:35 pmRNSPrice Monitoring Extension
5th Apr 20195:57 pmRNSNotice of AGM
22nd Mar 20194:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.